Please login or register to print this page.


Articles tagged ‘aspirin’

April 29, 2015

Global AF treatment market to peak in 2020

The global market for atrial fibrillation (AF) treatment will more than double in value from $4.6 billion in 2013 to peak sales of $9.4 billion in 2020, before declining to $5.7 billion by 2023 as novel oral anticoagulants (NOACs) become genericised, according to a recent report from research and consulting firm GlobalData.1

read more

August 5, 2014

Apixaban versus warfarin and aspirin: results from AVERROES and ARISTOTLE

The efficacy and safety of apixaban compared with aspirin are consistent in subgroups of patients who have previously attempted but failed Vitamin K antagonist (VKA) therapy, irrespective of the reason for discontinuation, according to a study published recently in the European Heart Journal.1

read more

August 5, 2014

Apixaban cost-effective in stroke prevention

Based on randomised trial data, apixaban is a cost-effective alternative to warfarin and aspirin, in vitamin K antagonists (VKA) suitable and VKA unsuitable patients with AF, respectively, according to a recent study.1

read more

May 28, 2014

Calcium scoring to guide aspirin use

Calcium scoring could help guide the treatment of coronary heart disease (CHD), by avoiding the unnecessary use of preventive medications, according to a report published recently in Circulation: Cardiovascular Quality and Outcomes.1

read more

August 30, 2013

Risks of aspirin with oral anticoagulation in patients with AF

Patients with atrial fibrillation (AF) receiving oral anticoagulation (OAC) are often treated with concomitant aspirin (ASA) therapy, even when they do not have cardiovascular disease, according to a study1 published recently in Circulation. Use of OAC and ASA was associated with significantly increased risk for bleeding, say the authors

read more

April 26, 2013

NOACs for stroke prevention in AF

Novel oral anticoagulants (NOACs) reduced stroke risk in the elderly population with atrial fibrillation (AF), and overcome many of the disadvantages of warfarin, according to a study1 published recently in the International Journal of General Medicine.

read more

February 28, 2013

Outcomes with aspirin versus apixaban in patients with AF

In an atrial fibrillation (AF) population, apixaban was superior to aspirin for stroke prevention. There were similar rates of major bleeding, in the presence of one or more stroke risk factors, with consistency of the treatment effect by CHADS2/CHA2DS2-VASc scores, according to a study1 published recently in Circulation: arrhythmia and electrophysiology.

read more

July 24, 2012

Aspirin the wrong easy option for AF management

Atrial fibrillation (AF) is set to double by 2050,1 according to a group of independent UK experts who reported recently.2 The report also states that, despite readily available checks, roughly half of AF patients still remain undetected.

read more

November 3, 2011

Aspirin unsafe and ineffective for stroke prevention in AF

Aspirin increases the risk of bleeding without decreasing the risk of stroke/thromboembolism sufficiently in patients with atrial fibrillation (AF), according to a study1 published recently in Thrombosis and Haemostasis.

read more

Members Area

Log in or Register now.



Subscribe to our RSS feed


Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.


    None Found


  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.